A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma
NCT07869043
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
1100
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
tilrekimig
OTHER:
Placebo
Sponsor
Pfizer